Stay updated on PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Sign up to get notified when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.

Latest updates to the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded Revision: v3.3.3; removed the HHS Vulnerability Disclosure link and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedStudy status updated to Completed with an actual completion date of 2025-09-22, and Last Update Posted and Revision metadata were added (Last Update Posted 2025-11-14; Revision: v3.3.2). A note in Publications indicates PubMed-sourced entries are auto-filled and may not all be about the study.SummaryDifference0.5%

- Check53 days agoChange DetectedRemoved a general funding-status notice that does not affect trial details, eligibility, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check67 days agoChange DetectedExpanded and updated the list of trial sites on the Study Details page, listing numerous French locations. This provides current enrollment options and contact points for potential participants.SummaryDifference0.3%

- Check95 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, and confirmed the NIH Clinical Center is open with sources. - Version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check103 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0SummaryDifference0.0%

Stay in the know with updates to PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAlbociclib & ctDNA for ESR1 Mutations Clinical Trial page.